Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex.
Isolation of highly enriched primary human microglia for functional studies.
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
Regulatory T cells in autoimmune neuroinflammation.
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model.
Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis.
MRI to Discriminate Pediatric MS from ADEM.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages.
IV immunoglobulin confounds JC virus antibody serostatus determination.
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
Evolution of the CNS myelin gene regulatory program.
Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor.
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »